Cytheris SA, of Paris, published data in Cell showing interleukin-7 (IL-7) was able to overcome many of the factors that thwart an effective immune response in diseases such as HIV infection and viral hepatitis. The study results also suggested how IL-7 therapy could be used to produce and expand specific T cells and promote a broad and durable immune-mediated antiviral response.